Clinically relevant differences in prothrombin time and INR values related to blood sample collection in plastic vs glass tubes

American Journal of Clinical Pathology

Volumn 124, Issue 6, 2005, Pages 902-909

  Fiebig, Eberhard W ^a,b   Etzell, Joan E ^a,c   Ng, Valerie L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood collection tubes; Glass; INR; International normalized ratio; Plastic; Prothrombin time; Warfarin therapy

Indexed keywords

WARFARIN;

ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG MEGADOSE; FREEZING; GLASS TUBE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; PLASTIC TUBE; PRIORITY JOURNAL; PROTHROMBIN TIME; TREATMENT OUTCOME; TUBE;

EID: 28444445610     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/LKYKCLPMPFG4JPUA     Document Type: Article

References (24)

1. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997;107:105-110.
2. Chantarangkul V, Tripodi A, Clerici M, et al. Assessment of the influence of citrate concentration on the international normalized ratio (INR) determined with twelve reagent-instrument combinations. Thromb Haemost. 1998;80:258-262.
3. Duncan EM, Casey CR, Duncan BM, et al. Effect of concentration of trisodium citrate anticoagulant on calculation of the international normalised ratio and the international sensitivity index of thromboplastin. Thromb Haemost. 1994;72:84-88.
4. Ingram GI, Hills M. The prothrombin time test: effect of varying citrate concentration. Thromb Haemost. 1976;36:230-236.
5. Adcock DM, Kressin DC, Marlar RA. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration. Am J Clin Pathol. 1998;109:595-599.
6. Peterson P, Gottfried EL. The effects of inaccurate blood sample volume on prothrombin time (PT) and activated partial thromboplastin time (aPTT). Thromb Haemost. 1982;47:101-103.
7. Reneke J, Etzell J, Leslie S, et al. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant. Am J Clin Pathol. 1998;109:754-757.
8. Flanders M, Crist R, Rodgers G. A comparison of blood collection in glass versus plastic Vacutainers on results of esoteric coagulation assays. Lab Med. 2003;34:732-735.
9. Gosselin RC, Janatpour K, Larkin EC, et al. Comparison of samples obtained from 3.2% sodium citrate glass and two 3.2% sodium citrate plastic blood collection tubes used in coagulation testing. Am J Clin Pathol. 2004;122:843-848.
10. Palmer RN, Gralnick HR. Cold-induced contact surface activation of the prothrombin time in whole blood. Blood. 1982;59:38-42.
11. Tripodi A, Chantarangkul V, Bressi C, et al. How to evaluate the influence of blood collection systems on the international sensitivity index: protocol applied to two new evacuated tubes and eight coagulometer/ thromboplastin combinations. Thromb Res. 2002;108:85-89.
12. Schulman S. Clinical practice; care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675-683.
13. Tyco Healthcare Group LP. Monoject Blue Stopper. Available at: http://www.kendallhq.com/catalog/prodlisting.asp. Accessed June 21, 2005.
14. National Committee for Clinical Laboratory Standards. Procedures for the collection of diagnostic blood specimens by venipuncture; approved standard. Wayne, PA: NCCLS; 2003.
15. National Committee for Clinical Laboratory Standards. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays; approved guideline. H2l-A4. 4th ed. Wayne, PA: NCCLS; 2003.
16. Ng VL, Levin J, Corash L, et al. Failure of the international normalized ratio to generate consistent results within a local medical community. Am J Clin Pathol. 1993;99:689-694.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
18. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995;346:1085-1087.
19. WHO Expert Committee on Biological Standardization. Annex 3: guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. In: World Health Organisation Technical Report Series. 48th report. No. 889. Geneva, Switzerland: World Health Organization; 1999;64-93.
20. Poller L, Van Den Besselaar AM, Jespersen J, et al. The effect of sample size on fresh plasma thromboplastin ISI determination. Br J Haematol. 1999;105:655-663.
21. Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem. 1995;41:444-447.
22. Lassen JF, Kjeldsen J, Antonsen S, et al. Interpretation of serial measurements of international normalized ratio for prothrombin times in monitoring oral anticoagulant therapy. Clin Chem. 1995;41:1171-1176.
23. Rapaport SI, Aas K, Owren PA. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest. 1955;34:9-19.
24. Dunn S. Compliance perspectives: the safe sharps race: a steady advance to the finish line. G-2 Compliance Report. 2004;VI:5-8.